Search our ?database which contains an extensive list of package inserts of hematology/oncology drugs as well as drugs used to treat comorbid conditions and diseases.
Our drug database contains the original package inserts and, where available, product monographs (OTC & Rx). ?This resource is organized by brand and generic names.
| ?Trade Name | INN | License Holder | Year |
| Abstral? | fentanyl | ProStrakan | 2011 |
| Adcetris? | brentuximab vedotin | Seattle Genetics | January 2012 |
| Adrucil? | 5-fluorouracil | 5-FU | TEVA Generics | |
| Agrylin? | anagrelide hydrochloride | Shire US Inc | 2003 |
| Alecensa? | alectinib | Genentech | Roche | 2015 |
| Alimta? | pemetrexed | Eli Lilly and Company | 2004 |
| Anzemet? | dolasetron mesylate | Sanofi (Aventis Pharmaceuticals) | 2003, 2011 |
| Aranesp? | darbepoetin alfa | Amgen Inc. | 2001 – 2003 |
| Aredia? | pamidronate disodium | Novartis Pharmaceuticals Corporation | May 2012 |
| Arimidex? | anastrozole | AstraZeneca | September 2002 |
| Aromasin? | exemestane tablets | Pfizer (Phramacia Oncology) | October 2008 |
| Avastin? | bevacizumab | Genentech | Roche | July 2009 |
A
Alemtuzumab (Campath?)
Berlex Laboratories, 2002
Alitretinoin gel 0.1% (Panretin?)
Ligand Pharmaceuticals Inc
Altretamine (Hexalen?)
MGI Pharma/Eisai Co. Ltd
Amifostine (Ethyol?)
MedImmune Oncology, Inc
Aminoglutethimide tablets (Cytadren?)
Novartis Pharmaceuticals Corporation, 2002
Aprepitant (Emend?)
Merck & Co., Inc, 2003
Arsenic trioxide injectable solution (Trisenox?)
Cell Therapeutics, Inc, March 2000
Asparaginase (Elspar?)
Merck & Co., Inc, 2003
B
Bevacizumab (Avastin?)?(Package Insert | Bevacizumab)
Genentech; July 2009
Bexarotene (Targretin?)
Eisai Inc, 2011
Bexarotene gel 1% (Targretin?)
Ligand Pharmaceuticals Inc.
Bicalutamide (Casodex?)?(Package Insert | Bicalutamide)
AstraZeneca, 2009
BiCNU? (carmustine)
Bristol-Myers Squibb Company, May 2011
Bleo-Kyowa (bleomycin sulphate)
ProStrakan, Inc, 2010
Bleomycin for Injection, USP
Faulding Pharmaceutical Co.
Bonviva? : Boniva? (ibandronate sodium)
Genentech, Inc/Roche Therapeutics Inc
Bonefos? (Clasteon?, Loron?) (sodium clodronate)
Bayer plc (UK)
Bortezomib for Injection (Velcade?)
Millennium Pharmaceuticals, Inc
Buserelin acetate (Suprefact?)
Sanofi-aventis Canada Inc
Busulfan (Busilvex?, Myleran?)
GlaxoSmithKline (GSK), 2004
C
Caelyx
Calcium Folinate
Calcium Levofolinate (Isovorin)
Campto
Campath? (Alemtuzumab)
Berlex Laboratories, 2002
Capecitabine (Xeloda?) tablets,
Genentech, Inc/Roche Therapeutics Inc
Carboplatin Aqueous Solution for Injection (Paraplatin?)
Bristol-Myers?Squibb/BMS, 2004
Cardioxane? (dexrazoxane for injection; ICRF 187)
Novartis Pharmaceuticals UK Ltd, 2012
Carmustine (BiCNU?)?(Package Insert Carmustine)
Bristol-Myers Squibb Company, May 2011
Casodex? (Bicalutamide) (Package Insert | Bicalutamide)
AstraZeneca, 2009
Cediranib / AZD2171 (Recentin?)
AstraZeneca
Cetuximab (Erbitux?)?(Package Insert | Cetuximab)
Bristol-Myers Squibb Company / Eli Lilly and Company, 2004/2012
Celebrex? (celecoxib) capsules?(Package Insert | celecoxib)
Pfizer Inc;?June 2009
Chlorambucil (Leukeran?)
GlaxoSmithKline (GSK), 2003
Chromic Phosphate P 32 (Phosphocol? P 32)
Mallinckrodt Inc., 2000
Cisplatin, USP (cis-diamminedichloroplatinum)
GensiaSicor Pharmaceuticals, Inc.
Cisplatin injection (Platinol?-AQ)
Bristol-Myers Squibb Company
Cladribine (Leustatin?)
Ortho Biotech Pproducts, L.P., 2002
Cladribine (Litak)
Clolar?Evoltra? (clofarabine injection)
Genzyme/Sanofi, 2004
Cyclophosphamide monohydrate (Cytoxan?)
Bristol-Myers Squibb Company, September 2005
Cytadren? (aminoglutethimide tablets)
Novartis Pharmaceuticals Corporation, 2002
Cytoxan? (cyclophosphamide monohydrate for injection)
Bristol-Myers Squibb Company, September 2005
Lyophilized Cytoxan? (cyclophosphamide for injection, USP)
MeadJohnson Oncology Products, July 2000
Cyprostat? (Cyproterone acetate)
Cytarabine for Injection, USP, (ara-C)
GensiaSicor Pharmaceuticals, Inc.
Cytarabine Liposome Injection (DepoCyt(e)?)
Pacira Pharmaceuticals
D
Dacarbazine for Injection, USP
Faulding Pharmaceutical Co.
Dasatinib?(Sprycel)
Daunorubicin Hydrochloride for Injection, USP
GensiaSicor Pharmaceuticals, Inc.
Decapeptyl
Denileukin Diftitox (Ontak?)
Ligand Pharmaceuticals Inc.
DepoCyt(e)? (Cytarabine Liposome Injection)
Pacira Pharmaceuticals
Dexamethasone sodium phosphate
Dexrazoxane for injection; ICRF 187 (Cardioxane?)
Novartis Pharmaceuticals UK Ltd, 2012
Dexrazoxane for injection (Zinecard?)?(Package Insert | Dexrazoxane for injection (Zinecard?)
Pfizer, Inc (Pharmacia & Upjohn Company), 1998
Disodium Folinate
Disodium Pamidronate
Docetaxel (Taxotere? Injection Concentrate)?(Package Insert Docetaxel Taxotere)
Sanofi (Aventis Pharmaceuticals), 2003, 2010
Dolasetron mesylate (Anzemet?)(Package Insert dolasetron mesylate)
Sanofi (Aventis Pharmaceuticals), 2003, 2011
Doxorubicin Hydrochloride (Rubex?)
MeadJohnson Oncology Products
Droxia?(Hydroxycarbamide)
E – H? I – M? N – R? S – W? X – Z
Last editorial review: July 19, 2017
Featured Image: Researcher in laboratory Courtesy: ? 2017 Fotolia. Used with permission.
Copyright ? 2017 Sunvalley Communication, LLC. All rights reserved. Republication or redistribution of Sunvalley Communication content, including by framing or similar means, is expressly prohibited without the prior written consent of Sunvalley Communication. Sunvalley Communication shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Onco?Zine, Oncozine and The Onco?Zine Brief are registered trademarks and trademarks of Sunvalley Communication around the world.
